Last updated on February 2019

Open Label Extension Study of AMX0035 in Patients With ALS

Brief description of study

This study will provide extended access to patients and assess longer-term outcomes on patients who have completed the Centaur study.

Detailed Study Description

The Centaur Open Label Extension Study (CENTAUR-OLE) is designed to provide longer term access to AMX0035 for patients with ALS who participated in the CENTAUR study. The study will assess longer term safety and therapeutic potential of AMX0035.

Clinical Study Identifier: NCT03488524

Contact Investigators or Research Sites near you

Start Over

James Berry, MD

Massachusetts General Hospital
Boston, MA United States
  Connect »

Margaret Owegi, DO

University of Massachusetts Memorial Medical Center
Worcester, MA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.